Document is current

Any future updates will be listed below

ASO Author Reflections: Rationale to Routinely Retest ER, PR and HER-2/neu Receptor Status in Residual Disease After Neoadjvuant Chemotherapy

Crossref DOI link: https://doi.org/10.1245/s10434-024-16020-2

Published Online: 2024-08-06

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark